International Conference of Drug Regulatory Authorities (ICDRA)-2024

Welcome

19th International Conference of Drug Regulatory Authorities (ICDRA), INDIA-2024

Since it was founded in 1980, the International Conference of Drug Regulatory Authorities (ICDRA) has brought together regulatory authorities from WHO Member States to strengthen collaboration and develop international consensus on regulatory priorities. ICDRA provides a unique forum to support and guide regulatory authorities, WHO and international stakeholders in confronting the challenges and highlighting the opportunities of today’s dynamic and innovative regulatory sector.

Delegates from regulatory authorities around the world will participate in an event programme designed to evoke ideas and discussion on the current key priorities in the regulatory environment while also ensuring valuable engagement with leading stakeholders across industry, research as well as healthcare professionals in the open pre-ICDRA conference.

The 19th ICDRA will facilitate focused discussions on quality issues, regulatory reforms and strengthening regulatory systems, safety of medical products, detection, prevention and response to substandard and falsified medical products, access to quality medical products, smart regulation of clinical trials, regulatory collaboration, harmonization, rationalization and reliance, access to new and novel technologies, regulation of novel medical products, regulation of herbal medicines, etc.

The theme of the conference: Smart Regulation: Delivering Quality Assured Medical Products for All”.

CDSCO welcome
loader

Smart Regulation: Delivering Quality Assured Medical Products for All.

about cdsco

About Us

To the 19th International Conference of Drug Regulatory Authorities (ICDRA)

The Central Drugs Standard Control Organization (CDSCO), Ministry of Health and Family Welfare, Govt. of India, in collaboration with World Health Organization (WHO) is hosting “19th International Conference of Drug Regulatory Authorities (ICDRA)” in New Delhi, India, 14th October- 18th October 2024”. The theme of this ICDRA is “Smart Regulation: Delivering Quality Assured Medical Products for All”. The event is a full five (5) day program, wherein the first 2 days are designated as PRE-ICDRA and the remaining 3 days are designated as ICDRA.

Pre-ICDRA is an open session, wherein the delegates and participants from Drugs Regulatory Authorities, Governments and inter-government organizations, Industries, Academia, Research organizations, NGOs, Non-profit organizations etc., while ICDRA is a REGULATORS ONLY session open for Drug Regulatory Authorities of WHO Member States.

The interested participants may register themselves on this portal and may follow subsequent communications related to confirmation of registration. On the side-lines of Pre-ICDRA, A few industry and research organizations may register themselves as EXHIBITORS to showcase their products/processes to the Drug Regulatory Authority community. The participants/exhibitors may refer to the Registration Manual prior to initiating the registration process.

The international participants, after successful registration, may be issued with specific VISA support letters from ICDRA Secretariat to facilitate the VISA issuance by Indian Embassies in the country.

Central Drugs Standard Control Organization, on behalf of Ministry of Health and Family Welfare, Govt. of India and World Health Organization (WHO) is delighted to invite you to participate in the 19th International Conference of Drug Regulatory Authorities (ICDRA) in New Delhi, India. You are requested to register at the earliest, as the seats are limited.

For any further clarifications, you may contact ICDRA Secretariat at support[at]icdra2024[dot]in

Shri. Apurva Chandra

Secretary, Ministry of Health and Family Welfare

Dear Colleagues,

Central Drugs Standard Control Organization (CDSCO), Ministry of Health and Family Welfare is organizing "19th International Conference of Drug Regulatory Authorities (ICDRA)”in collaboration with World Health Organization (WHO) from 14th October- 18th October 2024 in the capital city, New Delhi.

India has taken enormous initiatives in achieving and maintaining the good health of its citizens. Some of the path-breaking initiatives taken by the government in this regard are National Health Mission (NHM) to improve availability and access to affordable and quality healthcare, Ayushman Bharat health insurance scheme covering medical treatment for serious illnesses for about 500 million people, National Programme for Health Care for the Elderly (NPHCE) to provide separate, specialized, and comprehensive healthcare to the elderly including outreach services, Immunization, in which COVID 19 immunization program was the largest in the world and covered more than 90 percent of the population in a very short time, Malaria eradication, digital health etc. I find that it is important for drug regulators to look at current challenges being faced by various member states in ensuring the health of their population and ways to find accessible and affordable healthcare for all.

Further, India has the largest pool of scientists, manufacturers and exporters, engaged in the area of pharmaceutical product innovation and manufacturing. This conference will provide an opportunity for all the global drug regulatory authorities to interact, learn and share the best practices and harmonize the regulatory processes wherever feasible.

Once again, I invite you and your colleagues to participate this international conference.

image Secretary
image DCGI

Dr. Rajeev Singh Raghuvanshi

Drugs Controller General of India (CDSCO)

Dear Colleagues,

It gives me immense gratitude to announce that Central Drugs Standard Control Organization (CDSCO), Ministry of Health and Family Welfare, Govt. of India is hosting the 19th International Conference of Drugs Regulatory Authorities (ICDRA) in New Delhi India from 14th October to 18th October 2024 in collaboration with World Health Organization (WHO). You are aware that we had to postpone this event in the year 2020 due to COVD-19 pandemic, however, WHO had organized the Extraordinary Virtual International Conference of Drug Regulatory Authorities (ICDRA), from 20th - 24th September, 2021 and we were glad to share our experiences and best practices.

I take a great pride in welcoming the eminent Drugs Regulators from all over the world, renowned scientists, academicians, researchers, NGOs, consumer representatives, delegates of leading national & international pharmaceutical companies, non-profit organizations etc. to participate to the largest and prestigious gatherings for drug regulatory authorities.

Theme of the 19th ICDRA is “Smart Regulation: Delivering Quality Assured Medical Products for All”, which is very relevant to our collective responsibility towards making the timely availability of high quality, efficacious and safe medicines for entire healthcare ecosystem. Apart from this, the pandemic has also taught us to adopt the expedited and accelerated pathways for approval of drugs, diagnostics, and vaccines, which was based on the rigorous coordination and collaboration, harmonized processes, and regulatory reliance. Everyone appreciates that smart and risk based regulations are the need of the hour in light of resource constraints including workforce, making us to judiciously utilize them for newer requirements and to rely upon other regulators for established things.

I am sure that, the deliberations of 19th ICDRA will be more fruitful to provide concrete recommendations to NRAs, Governments of member countries and WHO for ensuring quick access to high quality medical products for all.

Insert title here